Journal of Antimicrobial Chemotherapy (2001) 48, 137-140
© 2001 The British Society for Antimicrobial Chemotherapy
Brief report |
The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice
a Department of Microbiology, Toho University School of Medicine, Tokyo; b Research Department, Research & Development Division, Hokuriku Seiyaku Co., Ltd, Fukui, Japan
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin, sparfloxacin and levofloxacin. Olamufloxacin was active against systemic infection in mice inoculated with both Gram-positive and -negative bacteria. Olamufloxacin had equal efficacy for experimental urinary tract infections in mice caused by Pseudomonas aeruginosa.
* Correspondence address. Research Department, Hokuriku Seiyaku Co., Ltd, 1-1 Inokuchi 37, Katsuyama, Fukui 911-8555, Japan. Tel: +81-779-88-5121; Fax: +81-779-88-3021; E-mail: satoshi.yoshizumi{at}hokuriku-seiyaku.co.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. L. Kadurugamuwa, K. Modi, J. Yu, K. P. Francis, T. Purchio, and P. R. Contag Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice Infect. Immun., July 1, 2005; 73(7): 3878 - 3887. [Abstract] [Full Text] [PDF] |
||||
